By Professor Matthew Gwyn Law

Journal articles

Kariminia A; Butler TG; Corben S; Kaldor JM; Levy MT; Law MG, 2005, 'Mortality among prisoners: how accurate is the Australian National Death Index?', Australian and New Zealand Journal of Public Health, 29, pp. 572 - 575

Habib R; Abdallah S; Law MG; Kaldor JM, 2005, 'Mortality rates among nuclear industry workers at Lucas Heights Science and Technology Centre', Australian and New Zealand Journal of Public Health, 29, pp. 229 - 237

Kent S; Dale C; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori D; Thomson S; Ramshaw I; Coupar B; Boyle D; Law MG; Wilson K; Ramsay AJ, 2005, 'Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3', Vaccine, 23, pp. 5009 - 5021, http://www.sciencedirect.com/science/article/B6TD4-4GD4PRX-3/2/ab250e7a3eab143e3b4b2966b01c461c

Zhou J; Kumarasamy N, 2005, 'Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD)', HIV Medicine, 6, pp. 216 - 223

Thiebault R; El-Sadr W; Friis-Moller N; Rickenbach M; Reiss P; d Arminio Monforte A; Morfeldt L; Fontas E; Kirk O; De Wit S; Calvo G; Law MG; Dabis F; Sabin C; Lundgren JD, 2005, 'Predictors of hypertension and changes of blood pressure in HIV-infected patients.', Antiviral Therapy, 10, pp. 811 - 823

Emery S; Workman C; Puls R; Bloch M; Baker D; Bodsworth NJ; Anderson JA; Crowe SM; Hoy JF; Aichelburg A; Ward LA; Boyle D; Law MG; Kelleher AD; Cooper DA, 2005, 'Randomised, Placebo-Controlled, Phase 1/2a Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-y in HIV-1 Infected Subjects', Human Vaccines, 1, pp. 232 - 238, http://www.landesbioscience.com/journals/vaccines/emeryHV1-6.pdf

Zhou J; Kumarasamy N; Ditangco R; Kamarulzaman A; Lee CK; Li P; Paton N; Phanuphak P; Pujari S; Vibhagool A; Wong WW; Zhang F; Chuah J; Frost K; Cooper DA; Law MG, 2005, 'The TREAT Asia HIV observational database - Baseline and retrospective data', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 38, pp. 174 - 179

Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6

Moyle GJ; Sawyer W; Law MG; Amin J; Hill A, 2004, 'Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies', Clinical Therapeutics, 26, pp. 92 - 97

Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384

Dale C; De Rose R; Stratov I; Chea S; Montefiori D; Thomson S; Ramshaw I; Coupar B; Boyle D; Law MG; Kent S, 2004, 'Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immuno deficiency virus', Journal of Virology, 78, pp. 13819 - 13828

O Sullivan BG; Gidding H; Law MG; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216

O'Sullivan BG; Gidding HF; Law M; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216, http://dx.doi.org/10.1111/j.1467-842x.2004.tb00477.x

Dale C; De Rose R; Wilson K; Croom H; Thomson S; Coupar B; Ramsay AJ; Purcell D; Ffrench R; Law MG; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent S, 2004, 'Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN[gamma] or IL-12', Vaccine, 23, pp. 188 - 197, http://www.sciencedirect.com/science/article/B6TD4-4CN9FR0-5/2/aa9e52964e8dec8ad797d2f13a3a639e

Clements MS; Prestage G; Grulich AE; Van De Ven PG; Kippax SC; Law MG, 2004, 'Modeling trends in HIV incidence among homosexual men in Australia 1995-2006', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 35, pp. 401 - 406

Carr AD; Workman C; Carey DL; Rogers GJ; Martin A; Baker DA; Wand HC; Law MG; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5

Law MG; Cheng AJ; Cooper DA; Carr AD, 2004, 'Objective evaluation of HIV lipodystrophy case definition in a randomized 96 week clinical trial', Antiviral Therapy, 9, pp. L8 - L9

Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, 5, pp. 192 - 200, http://thomasland.metapress.com/content/0gu76x27mmhe5ale/

Ward RL; Williams R; Law MG; Hawkins NJ, 2004, 'The CpG island methylator phenotype is not associated with a personal or family history of cancer', Cancer research, 64, pp. 7618 - 7621

Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD; Bartsch G; Dabis F; Houyez F; Loeliger E; Tressler R; Weller I; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Meester R; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J; de Wolf F; van der Ven E; Zaheri S; Van Valkengoed I; Bronsveld W; Weigel H; Brinkman K; Frissen P; ten Veen J; Hillebrand M; van Dam P; Schieveld S; Mulder J; van Gorp E; Meenhorst P; van Eeden A; Danner S; Claessen F; Perenboom R; Eeftinck Schattenkerk JK; Godfried M; Lange J; Lowe S; van der Meer J; Nellen F; Pogany K; van der Poll T; Prins J; Ruys T; van der Valk M; Wit F; Richter C; van Leusen R; Vriesendorp R; Jeurissen F; Kauffmann R; Koger E; Bravenboer B; ten Napel C; Sprenger HG; Law G; ten Kate RW; Leemhuis M; Kroon F; Schippers E; Schrey G; van der Geest S; Verbon A; Koopmans P; Keuter M; Telgt D; van der Ven A; van der Ende M; Gyssens I; de Marie S; Juttmann J; van der Heul C; Schneider M; Borleffs J; Hoepelman I; Jaspers C; Matute A; Schurink C, 2003, 'Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group', New England Journal of Medicine, 349, pp. 1993 - 2003, http://dx.doi.org/10.1056/NEJMoa030218

Porter K; Law M; Dabis F; Thiebaut R; Chêne G; Lawson-Ayayi S; Meyer L; Boufassa F; Hamouda O; Fischer K; Pezzotti P; Rezza G; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Amo J; del Romero J; van Asten L; van Benthem B; Prins M; Coutinho R; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Lee C; Johnson AM; Phillips AN; Babiker A; Darbyshire JH; Gill N; Porter K; Francioli P; Vanhems P; Egger M; Rickenbach M; Cooper D; Kaldor J; Ashton L; Vizzard J; Muga R; Day NE; De Angelis D, 2003, 'Estimating the effect of antiretroviral treatment during HIV seroconversion: Impact of confounding in observational data', HIV Medicine, 4, pp. 332 - 337, http://dx.doi.org/10.1046/j.1468-1293.2003.00168.x

Copeman M; Law MG; Batey RG, 2003, 'Injecting drug use in Australia: Needle/syringe programs prove their worth, but hepatitis C still on the increase (multiple letters)', Medical Journal of Australia, 179, pp. 119, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05458.x

Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; D'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD, 2003, 'Cardiovascular disease risk factors in HIV patients - Association with antiretroviral therapy. Results from the DAD study', AIDS, 17, pp. 1179 - 1193, http://dx.doi.org/10.1097/00002030-200305230-00010

Engels EA; Frisch M; Biggar RJ; Goedert JJ; Grulich AE; Law MG, 2003, 'Re: "estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus" (multiple letters)', American Journal of Epidemiology, 157, pp. 955 - 956, http://dx.doi.org/10.1093/aje/kwg084

Grulich AE, 2003, 'TWO AUTHORS REPLY', American Journal of Epidemiology, 157, http://dx.doi.org/10.1093/aje/kwg085

Ramasamy I; Law M; Collins S; Brooke F, 2003, 'Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease', Lancet Infectious Diseases, 3, pp. 214 - 222, http://dx.doi.org/10.1016/S1473-3099(03)00578-4

Dore GJ; MacDonald M; Law MG; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia.', Australian family physician, 32, pp. 796 - 798

Law M; Friis-Möller N; Weber R; Reiss P; Thiebaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Calvo G; El-Sadr W; De Wit S; Sabin CA; Lundgren JD, 2003, 'Modelling the 3-year risk of myocardial infarction among participants in the Data Collection of Adverse Events of Anti-HIV Drugs (DAD) study', HIV Medicine, 4, pp. 1 - 10, http://dx.doi.org/10.1046/j.1468-1293.2003.00138.x

Ramasamy I; Law M; Collins S; Brooke F, 2003, 'Variant Creutzfeldt-Jakob disease and the potential for its accidental transmission following surgery with contaminated instruments: The risk of transmission in Australia', Folia Neuropathologica, 41, pp. 1 - 10

Carr AD; Emery S; Law MG; Puls R; Lundgren JD; Powderly W, 2003, 'An objective case definition of lipodystrophy in HIV-infected adults: a case-control study', Lancet, 361, pp. 726 - 735

Carr AD; Law MG, 2003, 'An objective lipodystrophy severity grading scale using the lipodystrophy case definition score', Journal of Acquired Immune Deficiency Syndrome, 33, pp. 571 - 576

Friis-Moller N; Weber R; Reiss P; Thiebault R; Kirk O; d Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law MG; El-Sadr W; de Witt S; Sabin C; Philips A; Lundgren JD, 2003, 'Cardiovascular risk factors in HIV patients: association with antiretroviral therapy', AIDS, 17, pp. 1179 - 1193

Smith DE; Hudson J; Martin A; Freund J; Griffiths MR; Kalnins S; Law MG; Carr AD; Cooper DA, 2003, 'Centralised assessment of dual-energy x-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophy', HIV Clinical Trials, 4, pp. 45 - 49

Friis-Moller N; Sabin C; Weber R; d Arminio Monforte A; El-Sadr W; Reiss P; Thiebaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD, 2003, 'Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction', New England Journal of Medicine, 349, pp. 1993 - 2003

Amin J; Moore A; Carr AD; French MA; Law MG; Emery S; Cooper DA, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, 4, pp. 252 - 261

MacDonald MA; Law MG; Kaldor JM; Hales J; Dore GJ, 2003, 'Effectiveness of needle and syringe programmes for preventing HIV transmission', International Journal of Drug Policy, 14, pp. 353 - 357

Dore GJ; Law MG; MacDonald MA; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia', Journal of Clinical Virology, 26, pp. 171 - 184

Ioannidis JP; Trikalinos TA; Law MG; Carr AD, 2003, 'HIV lipodystrophy case definition using artificial neural network modelling.', Antiviral Therapy, 8, pp. 435 - 441

Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301

Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, 17, pp. 1094 - 1096

Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249

Law MG; Batey RG, 2003, 'Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase', Medical Journal of Australia, 178, pp. 197 - 198

Copeman M, 2003, 'Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase', Medical Journal of Australia, 179, pp. 119 - 119, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05458.x

Law MG; Batey RG, 2003, 'Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase', Medical Journal of Australia, 178, pp. 494 - 494, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05323.x

Brew BJ; Tisch S; Law MG, 2003, 'Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy', AIDS, 17, pp. 1094 - 1096

Birch C; Middleton T; Hales GP; Cooper DA; Law MG; Crowe S; Hoy JF; Emery S, 2003, 'Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 57 - 61

Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor JM; Loveday S; Powell E; Spencer J; Wodak AD, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, 32, pp. 717 - 724

Law MG; Friss-Moller N; Weber R; Reiss P; Thiebaut R; Kirk O; d Arminio Monforte A; Pradier C; Morfeldt L; Calvo G; El-Sadr W; De Wit S; Sabin C; Lundgren JD, 2003, 'Modelling the three-year risk of myocardial infarction among participants in the D:A:D study.', HIV Medicine, 4, pp. 1 - 10

Dore GJ; Freeman A; Law MG; Kaldor JM, 2003, 'Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings', Antiviral Therapy, 8, pp. 365 - 372

Freeman A; Law MG; Kaldor JM; Dore GJ, 2003, 'Predicting progression to cirrhosis in chronic hepatitis C virus infection', Journal of Viral Hepatitis, 10, pp. 285 - 293

Back to profile page